Captrust Financial Advisors Agios Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	BUY	$17.06 - $31.42 $511 - $942	30 Added 18.07%	196 $4,000
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $4,215 - $5,499	158 Added 1975.0%	166 $5,000
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $709 - $1,194	-24 Reduced 75.0%	8 $0
Q3 2021 Nov 16, 2021	SELL	$41.92 - $58.18 $23,936 - $33,220	-571 Reduced 94.69%	32 $1,000
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $58,567 - $68,928	-1,125 Reduced 65.1%	603 $33,000
Q1 2021 May 17, 2021	BUY	$44.23 - $57.5 $15,347 - $19,952	347 Added 25.13%	1,728 $89,000
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $664 - $930	-20 Reduced 1.43%	1,381 $60,000
Q3 2020 Nov 17, 2020	BUY	$33.87 - $55.93 $1,930 - $3,188	57 Added 4.24%	1,401 $49,000
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $46,300 - $71,877	1,344 New	1,344 $75,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.